Hostplus

Hostplus is an Australian superannuation fund serving the hospitality, tourism, recreation, and sport industries. Established in 1988, it offers retirement savings, insurance, and investment options to its members.

David Elia

CEO, Company Secretary and Board Member

Damien Frawley

Chairman of the Board of Directors and Nomination and Board Renewal Committee and Member of the People and Remuneration Committee and Special Investment Group

Sam Sicilia Ph.D

Chief Investment Officer

Past deals in Australasia

Cardiac Dimensions

Series E in 2025
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Fleet Space Technologies

Series D in 2024
Fleet Space Technologies operates a constellation of commercial micro-satellites, offering enhanced mineral exploration services globally. They have pioneered the world's first 3D printed all-metal patch antenna for space, significantly improving throughput efficiency.

Alimetry

Series A in 2024
Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal (GI) disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device senses the underlying motility of the stomach to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By providing insights into GI health, Alimetry aims to enhance patient care and improve the management of gastrointestinal disorders.

SafetyCulture

Venture Round in 2024
SafetyCulture develops a mobile-first operations platform that digitizes inspections, audits, and training processes. Its platform enables teams across various industries to capture data, manage assets, and report issues in real-time, promoting safety and operational excellence.

Gilmour Space Technologies

Series D in 2024
Gilmour Space Technologies is an Australia- and Singapore-based rocket company focused on developing and launching low-cost hybrid propulsion launch vehicles for small satellites. Founded in 2012, the company provides space-launch services for satellite deployment and orbital transportation, offering dedicated and rideshare launches, modular satellite bus configurations, and real-time flight monitoring to support a range of payloads. It serves commercial and defense customers, aiming to reduce launch costs and enable diverse missions across low Earth orbit and beyond.

Fleet Space Technologies

Series C in 2023
Fleet Space Technologies operates a constellation of commercial micro-satellites, offering enhanced mineral exploration services globally. They have pioneered the world's first 3D printed all-metal patch antenna for space, significantly improving throughput efficiency.

Cardiac Dimensions

Series D in 2023
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Morse Micro

Series B in 2022
Morse Micro is a wireless semiconductor company developing low-power Wi-Fi HaLow chips for the Internet of Things. Built by Wi‑Fi pioneers and industry veterans, the company focuses on long-range, energy-efficient connectivity across IoT applications such as surveillance, access control, industrial automation, and mobile devices. Its IP and patents support the design of its chips. Headquartered in Australia with offices in China and the United States, Morse Micro aims to deliver affordable, scalable IoT connectivity for a wide range of devices.

Nourish Ingredients

Series A in 2022
Nourish Ingredients is a food technology company based in Canberra, Australia, that specializes in creating fat molecules identical to those found in animals, using innovative precision fermentation techniques. Founded in 2019, the company developed proprietary strains that can mass-produce these fat molecules, allowing for the production of plant-based foods that closely mimic the flavor, aroma, and cooking experience associated with animal fats. By providing alternatives to traditional animal-based ingredients, Nourish Ingredients aims to enhance the quality of plant-based products, making them more appealing to consumers seeking authentic taste without the environmental and ethical concerns related to animal agriculture.

Hysata

Series A in 2022
Hysata is focused on advancing hydrogen electrolyzer technology to facilitate the production of green hydrogen, aiming to significantly reduce costs to below $2 per kilogram. This innovative approach is rooted in research from the University of Wollongong's ARC Centre of Excellence for Electromaterials Science, led by Professor Gerry Swiegers. The company’s electrolyzers operate by using electricity to separate water into hydrogen and oxygen, thereby supporting the transition from fossil fuels to sustainable energy sources. Hysata's initiatives are designed to play a crucial role in helping businesses achieve net-zero emissions and accelerate the global move towards environmentally friendly energy solutions.

Zeller

Series B in 2022
Zeller is an Australian fintech company that provides an integrated payments and financial services platform for small and medium-sized businesses. Based in Melbourne and founded in 2020, Zeller enables businesses to accept payments in-store and online, manage finances, and pay recipients, with direct connectivity to bank accounts for fast transfers. The platform consolidates payments, finance management, and payouts into a single ecosystem to simplify cash flow and bookkeeping, reducing the time spent onboarding and coordinating multiple providers. It emphasizes a simple online sign-up and, in some offerings, no contract necessary, helping Australian businesses get paid, access their money, and better manage their finances.

Fleet Space Technologies

Series B in 2021
Fleet Space Technologies operates a constellation of commercial micro-satellites, offering enhanced mineral exploration services globally. They have pioneered the world's first 3D printed all-metal patch antenna for space, significantly improving throughput efficiency.

Gilmour Space Technologies

Series C in 2021
Gilmour Space Technologies is an Australia- and Singapore-based rocket company focused on developing and launching low-cost hybrid propulsion launch vehicles for small satellites. Founded in 2012, the company provides space-launch services for satellite deployment and orbital transportation, offering dedicated and rideshare launches, modular satellite bus configurations, and real-time flight monitoring to support a range of payloads. It serves commercial and defense customers, aiming to reduce launch costs and enable diverse missions across low Earth orbit and beyond.

Athena

Series D in 2021
Athena specializes in digital home lending, connecting wholesale funds with prime Australian mortgage borrowers. It offers competitive interest rates, aiming to maintain low rates for both new and existing customers. Athena's platform enables online loan applications, swift approvals, and convenient management without requiring in-person meetings.

Cardiac Dimensions

Series C in 2020
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Ena Respiratory

Series A in 2020
Ena Respiratory Pty Ltd is a biotechnology company based in Melbourne, Australia, focused on transforming the treatment and prevention of respiratory infections. Incorporated in 2020, the company develops synthetic innate immunomodulators aimed at preventing respiratory viral and bacterial infections. Ena Respiratory specializes in novel Toll-like receptor 2 (TLR2) receptor agonists that activate the innate immune system within the respiratory tract. This targeted approach allows for topical delivery to the airways, effectively preventing the dissemination of infections to the lungs. The company's innovations aim to enhance the effectiveness of vaccines and safeguard patients with pre-existing lung conditions from critical complications related to respiratory diseases.

Myriota

Series B in 2020
Myriota Pty. Ltd. is an Australian company based in Adelaide that specializes in developing low-power micro transmitters for satellite connectivity, primarily targeting the Internet of Things (IoT) market. Founded in 2015, Myriota's technology enables secure data transmission by using its low-power modules, which can be seamlessly integrated into various IoT devices. These devices send small packets of data to low Earth orbit satellites and ground stations, facilitating remote communication and monitoring. The firm's solutions cater to a diverse range of applications, including data-driven agriculture, resource asset management in sectors like oil and gas, mining, environmental monitoring, and defense. Myriota's innovations aim to enhance operational efficiency, reduce costs, and support data-driven decision-making across multiple industries.

Athena

Series C in 2019
Athena specializes in digital home lending, connecting wholesale funds with prime Australian mortgage borrowers. It offers competitive interest rates, aiming to maintain low rates for both new and existing customers. Athena's platform enables online loan applications, swift approvals, and convenient management without requiring in-person meetings.

Athena

Series B in 2018
Athena specializes in digital home lending, connecting wholesale funds with prime Australian mortgage borrowers. It offers competitive interest rates, aiming to maintain low rates for both new and existing customers. Athena's platform enables online loan applications, swift approvals, and convenient management without requiring in-person meetings.

Cardiac Dimensions

Series B in 2018
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.

Artesian VC

Venture Round in 2017
Artesian VC is an alternative investment management company that specializes in early-stage venture capital, particularly in the clean energy sector. Established in 2004 after spinning out from ANZ Banking Group, the company has evolved to manage a range of specialized funds, with a focus on seed and follow-on investments in startups sourced from approved accelerators, incubators, and academic programs. Artesian's investment strategy emphasizes partnerships with leading organizations in the startup ecosystem, enabling it to identify and support high-potential ventures. With offices in Sydney, Melbourne, Shanghai, New York, London, and Singapore, the company has built a global presence and has successfully raised over AUD 255 million for its various funds. Additionally, Artesian has expanded its reach through initiatives like its China VC Fund and plans for a Southeast Asia VC Fund, underscoring its commitment to fostering innovation in diverse markets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.